Xtx Topco LTD Entera Bio Ltd. Transaction History

Xtx Topco LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$4.43 - $6.29 $46,218 - $65,623	-10,433 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$2.92 - $6.5 $3,287 - $7,319	-1,126 Reduced 9.74%	10,433 $62,000
Q1 2021 May 14, 2021	BUY	$1.16 - $6.9 $13,408 - $79,757	11,559 New	11,559 $44,000

4.27M

3.9K

Ticker ENTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,809,900
Market Cap $53M
Description
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.